We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

3 hedge funds and large institutions have $7K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% less capital invested

Capital invested by funds: $9K → $7K (-$2K)

25% less funds holding

Funds holding: 4 → 3 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
QCIG
Quad-Cities Investment Group
Iowa
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
HFBOT
1
Home Federal Bank of Tennessee
Tennessee
$6K – – –
ACM
2
Academy Capital Management
Texas
$1K – – –
QCIG
3
Quad-Cities Investment Group
Iowa
– -$1K -10,600 Closed

PVCT Hedge Fund Activity: Q4 2019 in Review

3 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q4 2019, worth a combined $7K — down 22% from $9K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PVCT and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Quad-Cities Investment Group, exiting entirely with an estimated $1K sold.

  • 3 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q4 2019, down from 4 in Q3 2019.
  • Funds reported $7K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q4 2019, down 22% quarter-over-quarter.
  • 0 funds opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q4 2019 and 1 closed out, a net change of -1 holder.
  • The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) seller in Q4 2019 was Quad-Cities Investment Group, an estimated $1K sold.

Based on aggregated 13F filings for Q4 2019.